Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
2011
ISSN/ISBN: 0385-0684 PMID: 22189231 Document Number: 651362
A 64-year-old man was admitted to our hospital for 6th-line chemotherapy. Chest X-ray film and computed tomographic (CT) scan showed right-sided pleural thickening with multiple lung tumors. Repeated treatment with carboplatin (AUC 6), paclitaxel (200 mg/m(2)) and bevacizumab (150 mg/kg) on day 1 every 21 days was effective for this patient. Chemotherapy with bevacizumab may be effective for patients with multi-recurrent adenocarcinoma.